Endo Pharmaceuticals
From Wikipedia, the free encyclopedia
| Endo Pharmaceuticals | |
|---|---|
| Type | Public NYSE: ENDP |
| Founded | |
| Headquarters | Chadds Ford, Pennsylvania |
| Industry | Pharmaceuticals |
| Website | www.endo.com |
Endo became Endo Pharmaceuticals Inc. as a result of a management buyout from DuPont Merck in 1997. Endo is a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.
Endo rents some lab space from Novartis, at the Novartis production facility in Lincoln, Nebraska. At this lab, there is quality control testing of the Endo products that are producted on-site. At this particular Novartis production site, products such as TheraFlu, Triaminic and Buckley's are produced, as well as all of the Excedrin distributed across the entire nation.
[edit] Personnel
- Chief financial officer: Charles A. Rowland Jr. (as of December 2006, replacing Jeff Black) [1]
- The company's sales force numbers 590 [1]
[edit] Products[2]
- Amantadine (Symmetrel)
- Carbidopa with levodopa (Carbidopa/Levodopa USP)
- Frovatriptan (Frova)
- Hydrocodone with acetominophen (Zydone)
- Hydrocodone with homatropine (Hycodan)
- Lidocaine (Lidoderm)
- Lidocaine with tetracaine (Synera)
- Molindone (Moban)
- Oxycodone with acetominophen (Percocet, Endocet)
- Oxycodone with aspirin (Percodan)
- Oxymorphone (Opana)
[edit] References
- a b Staff. "Endo Pharmaceuticals names new CFO", Delaware News Journal, December 6, 2006. Retrieved on 2006-12-06.
- ^ Product Listing. Endo Pharmaceuticals (2006). Retrieved on 2006-12-06.
 |
This U.S. manufacturing company-related article is a stub. You can help Wikipedia by expanding it. |
